Stereotactic body radiotherapy in the treatment of Pancreatic Adenocarcinoma in elderly patients

Radiation Oncology

Volumn 8, Issue 1, 2013, Pages

  Kim, Carolyn H ^a   Ling, Diane C ^a   Wegner, Rodney E ^a   Flickinger, John C ^a   Heron, Dwight E ^a   Zeh, Herbert ^a   Moser, Arthur J ^b   Burton, Steven A ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GEMCITABINE;

AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CAUSE SPECIFIC SURVIVAL; CLINICAL ARTICLE; CYBERKNIFE; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; MALE; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PRESCRIPTION; RADIATION DOSE FRACTIONATION; RADIOSURGERY EQUIPMENT; ROBOTICS; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT FAILURE; ADENOCARCINOMA; DISEASE FREE SURVIVAL; KAPLAN MEIER METHOD; MORTALITY; PANCREATIC NEOPLASMS; PROCEDURES; RADIOSURGERY; RETROSPECTIVE STUDY; VERY ELDERLY;

ADENOCARCINOMA; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; PANCREATIC NEOPLASMS; RADIOSURGERY; RETROSPECTIVE STUDIES;

EID: 84885443905     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-8-240     Document Type: Article

References (30)

1. Hidalgo M. Pancreatic cancer medical progress. N Engl J Med 2010, 362(17):1605. 10.1056/NEJMra0901557, 20427809.
2. Shore S, Vimalachandran D, Raraty MGT, Ghaneh P. Cancer in the elderly: pancreatic cancer. Surg Oncol 2004, 13:201-210. 10.1016/j.suronc.2004.11.001, 15615658.
3. Werner C. The Older Population: 2010 2011, U.S. Census Bureau.
4. Siegel R, Naishadham D, Jemal A. Cancer Statistics, 2012. CA Cancer J Clin 2012, 62:10-29. 10.3322/caac.20138, 22237781.
5. Hatzaras I, Schmidt C, Klemanski D, Muscarella P, Melvin WS, Ellison EC, Bloomston M. Pancreatic resection in the octogenarian: a safe option for pancreatic malignancy. J Am Coll Surg 2011, 212:373-377. 10.1016/j.jamcollsurg.2010.10.015, 3157147, 21227721.
6. Matsumoto K, Miyake Y, Kato H, Kawamoto H, Imagawa A, Toyokawa T, Nakatsu M, Ando M, Hirohata M, Yamamoto K. Effect of low-dose gemcitabine on unresectable pancreatic cancer in elderly patients. Digestion 2011, 84:230-235. 10.1159/000330384, 21860243.
7. Vesper J, Bolke B, Wille C, Gerber PA, Matuschek, Peiper M, Steiger HJ, Budach W, Lammering G. Current concepts in stereotactic radiosurgery - a neurosurgical and radioncological point of view. Eur J Med Res 2009, 14(3):93-101. 10.1186/2047-783X-14-3-93, 3352064, 19380278.
8. Chang BK, Timmerman RD. Stereotactic body radiation therapy: a comprehensive review. Am J Clin Oncol 2007, 30(6):637-644. 10.1097/COC.0b013e3180ca7cb1, 18091059.
9. Voynov G, Heron DE, Burton S, Grandis J, Quinn A, Ferris R, Ozhasoglu C, Vogel W, Johnson J. Frameless stereotactic radiosurgery for recurrent head and neck carcinoma. Technol Cancer Res Treat 2006, 5(5):529-535.
10. Heron DE, Ferris RL, Karamouzis M, Andrade RS, Deeb EL, Burton S, Gooding WE, Branstetter BF, Mountz JM, Johnson JT, Argiris A, Grandis JR, Lai SY. Stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: results of a phase I dose-escalation trial. Int J Radiat Oncol Biol Phys 2009, 75:1493-1500. 10.1016/j.ijrobp.2008.12.075, 19464819.
11. Chang DT, Schellenberg D, Shen J, Kim J, Goodman KA, Fisher GA, Ford JM, Desser T, Quon A, Koong AC. Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas. Cancer 2009, 115(3):665-672. 10.1002/cncr.24059, 19117351.
12. Rwigema JC, Parikh SD, Heron DE, Howell M, Zeh H, Moser AJ, Bahary N, Quinn A, Burton SA. Stereotactic body radiotherapy in the treatment of advanced adenocarcinoma of the pancreas. Am J Clin Oncol 2011, 34:63-69. 10.1097/COC.0b013e3181d270b4, 20308870.
13. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958, 53:457-481.
14. Cox DR. Regression models and life tables. J R Stat Soc 1972, 74:187-220.
15. Hodul P, Tansey J, Golts E, Oh D, Pickleman J, Aranha GV. Age is not a contraindication to pancreaticoduodenectomy. Am Surg 2001, 67:270-276.
16. Lightner AM, Glasgow RE, Jordan TH, Krassner AD, Way LW, Mulvihill SJ, Kirkwood KS. Pancreatic resection in the elderly. J Am Coll Surg 2004, 198:697-706. 10.1016/j.jamcollsurg.2003.12.023, 15110802.
17. Smith SL, Hampson F, Duxbury M, Rae DM, Sinclair MT. Computed tomography after radical pancreaticoduodenectomy (Whipple's procedure). Clin Radiol 2008, 63:921-928. 10.1016/j.crad.2007.10.012, 18625359.
18. Makary MA, Winter JM, Cameron JL, Campbell KA, Chang D, Cunningham SC, Riall TS, Yeo CJ. Pancreaticoduodenectomy in the very elderly. J Gastrointest Surg 2006, 10:347-356. 10.1016/j.gassur.2005.12.014, 16504879.
19. Scurtu R, Bachellier P, Oussoultzoglou E, Rosso E, Maroni R, Jaeck D. Outcome after pancreaticoduodenectomy for cancer in elderly patients. J Gastrointest Surg 2006, 10:813-822. 10.1016/j.gassur.2005.12.010, 16769537.
20. Merl MY, Li J, Saif MW. The first-line treatment for advanced pancreatic cancer. J Pancreas 2010, 11(2):148-150.
21. Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K, Schramm H, Fahlke J, Zuelke C, Burkart C, Gutberlet K, Kettner E, Schmalenberg H, Weigang-Koehler K, Bechstein WO, Niedergethmann M, Schmidt-Wolf I, Roll L, Doerken B, Riess H. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer. JAMA 2007, 297:267-277. 10.1001/jama.297.3.267, 17227978.
22. Hentic O, Dreyer C, Rebours V, Zappa M, Lévy P, Raymond E, Ruszniewski P, Hammel P. Gemcitabine in elderly patients with advanced pancreatic cancer. World J Gastroenterol 2011, 17(30):3497-3502. 10.3748/wjg.v17.i30.3497, 3163247, 21941416.
23. Horowitz DP, Hsu CC, Wang J, Makary MA, Winter JM, Robinson R, Schulick RD, Cameron JL, Pawlik TM, Herman JM. Adjuvant chemoradiation therapy after pancreaticoduodenectomy in elderly patients with pancreatic adenocarcinoma. Int J Radiat Oncol Biol Phys 2011, 80:1391-1397. 10.1016/j.ijrobp.2010.04.003, 20643511.
24. Koong AC, Le QT, Ho A, Fong B, Fisher G, Cho C, Ford J, Poen J, Gibbs IC, Mehta VK, Kee S, Trueblood W, Yang G, Bastidas JA. Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 2004, 58:1017-1021. 10.1016/j.ijrobp.2003.11.004, 15001240.
25. Koong AC, Christofferson E, Le QT, Goodman KA, Ho A, Kuo T, Ford JM, Fisher GA, Greco R, Norton J, Yang GP. Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 2005, 63:320-323. 10.1016/j.ijrobp.2005.07.002, 16168826.
26. Schellenberg D, Goodman KA, Lee F, Chang S, Kuo T, Ford JM, Fisher GA, Quon A, Desser TS, Norton J, Greco R, Yang GP, Koong AC. Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 2008, 72:678-686. 10.1016/j.ijrobp.2008.01.051, 18395362.
27. Rwigema JC, Heron DE, Parikh SD, Zeh HJ, Moser JA, Bahary N, Ashby K, Burton SA. Adjuvant stereotactic body radiotherapy for resected pancreatic adenocarcinoma with close or positive margins. J Gastrointest Canc 2012, 43:70-76.
28. Katz MH, Fleming JB, Bhosale P, Varadhachary G, Lee JE, Wolff R, Wang H, Abbruzzese J, Pisters PW, Vauthey JN, Charnsangavej C, Tamm E, Crane CH, Balachandran A. Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators. Cancer 2012, 118(23):5749-5756. 10.1002/cncr.27636, 22605518.
29. Gastrointestinal Tumor Study Group Comparative therapeutic trial of radiation with or without chemotherapy in pancreatic carcinoma. Int J Radiat Oncol Biol Phys 1979, 5:1643-1647. Gastrointestinal Tumor Study Group.
30. Klaassen DJ, MacIntyre JM, Catton GE, Engstrom PF, Moertel CG. Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil - an Eastern Cooperative Oncology Group study. J Clin Oncol 1985, 3:373-378.